Dive into the archives.


  • A New Cause for MS?

    By Henry L. Davis NEWS MEDICAL REPORTER October 15, 2009, 6:36 AM Buffalo physicians announced Wednesday that they have started a large study that could overturn thinking about the generally accepted cause for multiple sclerosis. MS is believed to stem from an abnormal response of the body’s immune system directed against the fatty sheath that [...]

TAG / CLOUD

AAN, alemtuzumab, Avonex, Bayer, Betaseron, Biogen, BioMS Medical Corp, CCSVI, CIS, Cladribine, CLARITY, cognitive dysfunction, Copaxone, daclizumab, dirucotide, discovery, EAE, ECTRIMS, Elan, Fampridine-SR, FDA, FDA fast track status, fingolimod, FTY-720, Gilenia, interferons, laquinimod, Marijuana, Merck, Merck/Serono, Novartis, Oral MS Therapies, Phase III, PML, Rebif, remyelination, RRMS, side effects, smoking, SPMS, stem cells, Teriflunomide, Teva, therapy, Tysabri

Archives



Follow me on Twitter
Fave this on Technorati


Bookmark and Share


Wordpress Engine. Upstart Theme. Better Project.